American Heart Association (AHA): Scientific Sessions 2025 Highlights
Description
American Heart Association (AHA): Scientific Sessions 2025 Highlights
Summary
The American Heart Association (AHA) Scientific Sessions is an annual, four-day conference that brings together cardiovascular healthcare professionals from around the world to share the latest advances, research, and guidelines in heart and vascular medicine.
AHA 2025 took place in New Orlkeans, Louisiana, between 7-10 November 2025.GlobalData's cardiovascular & metabolic team attended industry-sponsored and scientific sessions where key therapies were featured, the contents of which were analyzed to create this AHA 2025 Highlights report.
Scope
Indications, companies, and therapies discussed -
Reasons to Buy
This Pdf deliverable provides analysis on key presentations from the conference, and what they mean for your strategy, covering disease areas such as Obesity, Heart Failure, Pulmonary Arterial Hypertension, Dyslipidemia, and more.
Inside the report you’ll find -
Summary
The American Heart Association (AHA) Scientific Sessions is an annual, four-day conference that brings together cardiovascular healthcare professionals from around the world to share the latest advances, research, and guidelines in heart and vascular medicine.
AHA 2025 took place in New Orlkeans, Louisiana, between 7-10 November 2025.GlobalData's cardiovascular & metabolic team attended industry-sponsored and scientific sessions where key therapies were featured, the contents of which were analyzed to create this AHA 2025 Highlights report.
Scope
Indications, companies, and therapies discussed -
- Novo Nordisk - Semaglutide
- Viking Therapeutics - VK2735
- SHR-1918
- BacNav
- Satralizumab
Reasons to Buy
This Pdf deliverable provides analysis on key presentations from the conference, and what they mean for your strategy, covering disease areas such as Obesity, Heart Failure, Pulmonary Arterial Hypertension, Dyslipidemia, and more.
Inside the report you’ll find -
- Emerging trends in cardiovascular and metabolic indications
- Insights into the disease areas that took precedence at the conference
- Key takeaways from headline sessions and late-breaking data
- Clinical and commercial implications of notable presentations
Table of Contents
20 Pages
- 1. Conference Overview
- 2. Industry Session Overview
- 3. Conference Analysis by Key Therapy
- 4. Key Presentations:
- GLP-1RAs
- Hyperlipidemia
- Heart Failure
- Pulmonary Arterial Hypertension
- 5. Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.


